大腸菌(ExPEC)ワクチンの世界市場...市場調査レポートについてご紹介

【英文タイトル】MarketVIEW: E.coli (ExPEC) vaccines - Global vaccine overview

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

※レポート紹介PDF⇒http://www.vaczine-analytics.com/VAMV064_TOC_151127.pdf

****This product is composed of two forecast models and a summary presentation

Title page
Author’s note
Contents
Executive summary
ExPEC vaccines: Commercial model: key outputs
ExPEC vaccines: sales by scenario (base pricing) to 2030
ExPEC vaccines: sales by scenario (low pricing) to 2030
ExPEC vaccines: sales by scenario (high pricing) to 2030
Modelling commercial potential
The role of an ExPEC vaccine
ExPEC: disease associations
ExPEC vaccine: potential indications
ExPEC vaccine: potential target populations
ExPEC vaccine target product profile (TPP)
Key model assumptions
Key model assumptions: scenarios
Pricing assumptions: disease burden comparisons
Pricing assumptions: bacteraemias – comparator table
ExPEC – Disease background and epidemiology
The pathogen
Pathogenic types
E.coli and bacteraemias
Bacteraemias: hospital admissions – US, 2000-2013
Bacteraemias: by age group US, 2013
Bacteraemias: mortality, United Kingdom
Bacteraemias: UK comparison to other hospital pathogens
Bacteraemias: by age and gender, England
Bacteraemias: sources of, England
Bacteraemias: community-acquired, England
Bacteraemias: France
Bacteraemias: France, clinical characteristics
E.coli: infant sepsis and meningitis
E.coli and healthcare-associated infections
Urinary tract infections, uncomplicated
Urinary tract infections, uncomplicated: US burden
Urinary tract infections, uncomplicated: hospitalization
Urinary tract infections, uncomplicated: treatment
Urinary tract infections, uncomplicated: recurrence
Urinary tract infections, uncomplicated: impact
E. coli antibiotic resistance trends
E.coli – antibiotic resistance trends: global dynamics
E.coli – antibiotic resistance trends (WHO report)
EU E.coli – antibiotic resistance trends (1)
EU E.coli – antibiotic resistance trends (2)
ExPEC vaccines: R&D pipeline
Vaccine R&D pipeline: overview
Vaccine R&D pipeline: JNJ-860/EcoXyn-4V
Target risk groups for JNJ-860/EcoXyn-4V vaccine
JNJ-860/EcoXyn-4V vaccine: status
Vaccine R&D pipeline: relevance E. coli O serotypes
Vaccine R&D pipeline: other HAI infection targets
Vaccine R&D pipeline: potential clinical strategy
ExPEC vaccines: methodology
Vaccine coverage rates: case studies
Vaccine coverage rates: private self-pay
Vaccine coverage rates: pneumovax benchmarks
Demographic and epidemiological model inputs
Bibliography
VacZine Analytics
Disclaimer

*** PAGES: ~67 MS PowerPoint slides, fully referenced/sourced. Available in .pdf form


【レポート販売概要】

■ タイトル:大腸菌(ExPEC)ワクチンの世界市場
■ 英文:MarketVIEW: E.coli (ExPEC) vaccines - Global vaccine overview
■ 発行日:2015年11月
■ 調査会社:VacZine Analytics
■ 商品コード:VACZ51202
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。